Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

OBJECTIVE: To provide an update to the original Surviving Sepsis Campaign clinical management guidelines, "Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock," published in 2004. DESIGN: Modified Delphi method with a consensus conference of 55 international experts, several subsequent meetings of subgroups and key individuals, teleconferences, and electronic-based discussion among subgroups and among the entire committee. This process was conducted independently of any industry funding. METHODS: We used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system to guide assessment of quality of evidence from high (A) to very low (D) and to determine the strength of recommendations. A strong recommendation (1) indicates that an intervention's desirable effects clearly outweigh its undesirable effects (risk, burden, cost) or clearly do not. Weak recommendations (2) indicate that the tradeoff between desirable and undesirable effects is less clear. The grade of strong or weak is considered of greater clinical importance than a difference in letter level of quality of evidence. In areas without complete agreement, a formal process of resolution was developed and applied. Recommendations are grouped into those directly targeting severe sepsis, recommendations targeting general care of the critically ill patient that are considered high priority in severe sepsis, and pediatric considerations. RESULTS: Key recommendations, listed by category, include early goal-directed resuscitation of the septic patient during the first 6 hrs after recognition (1C); blood cultures before antibiotic therapy (1C); imaging studies performed promptly to confirm potential source of infection (1C); administration of broad-spectrum antibiotic therapy within 1 hr of diagnosis of septic shock (1B) and severe sepsis without septic shock (1D); reassessment of antibiotic therapy with microbiology and clinical data to narrow coverage, when appropriate (1C); a usual 7-10 days of antibiotic therapy guided by clinical response (1D); source control with attention to the balance of risks and benefits of the chosen method (1C); administration of either crystalloid or colloid fluid resuscitation (1B); fluid challenge to restore mean circulating filling pressure (1C); reduction in rate of fluid administration with rising filing pressures and no improvement in tissue perfusion (1D); vasopressor preference for norepinephrine or dopamine to maintain an initial target of mean arterial pressure > or = 65 mm Hg (1C); dobutamine inotropic therapy when cardiac output remains low despite fluid resuscitation and combined inotropic/vasopressor therapy (1C); stress-dose steroid therapy given only in septic shock after blood pressure is identified to be poorly responsive to fluid and vasopressor therapy (2C); recombinant activated protein C in patients with severe sepsis and clinical assessment of high risk for death (2B except 2C for postoperative patients). In the absence of tissue hypoperfusion, coronary artery disease, or acute hemorrhage, target a hemoglobin of 7-9 g/dL (1B); a low tidal volume (1B) and limitation of inspiratory plateau pressure strategy (1C) for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS); application of at least a minimal amount of positive end-expiratory pressure in acute lung injury (1C); head of bed elevation in mechanically ventilated patients unless contraindicated (1B); avoiding routine use of pulmonary artery catheters in ALI/ARDS (1A); to decrease days of mechanical ventilation and ICU length of stay, a conservative fluid strategy for patients with established ALI/ARDS who are not in shock (1C); protocols for weaning and sedation/analgesia (1B); using either intermittent bolus sedation or continuous infusion sedation with daily interruptions or lightening (1B); avoidance of neuromuscular blockers, if at all possible (1B); institution of glycemic control (1B), targeting a blood glucose < 150 mg/dL after initial stabilization (2C); equivalency of continuous veno-veno hemofiltration or intermittent hemodialysis (2B); prophylaxis for deep vein thrombosis (1A); use of stress ulcer prophylaxis to prevent upper gastrointestinal bleeding using H2 blockers (1A) or proton pump inhibitors (1B); and consideration of limitation of support where appropriate (1D). Recommendations specific to pediatric severe sepsis include greater use of physical examination therapeutic end points (2C); dopamine as the first drug of choice for hypotension (2C); steroids only in children with suspected or proven adrenal insufficiency (2C); and a recommendation against the use of recombinant activated protein C in children (1B). CONCLUSIONS: There was strong agreement among a large cohort of international experts regarding many level 1 recommendations for the best current care of patients with severe sepsis. Evidenced-based recommendations regarding the acute management of sepsis and septic shock are the first step toward improved outcomes for this important group of critically ill patients.

Mediciones in situ de TS para el krill (Euphasia superba) a 120 Khz. Verano austral 1998. Perú antar IX

Se realizaron mediciones de la Fuerza de Blanco (TS) del krill (Euphausia superba) durante los 29 lances efectuados en el Crucero de Evaluación Hidroacústica utilizando la ecosonda SIMRAD EK 500 a bordo del BIC Humboldt entre los días 12 y 24 de enero de 1998 a lo largo del Estrecho de Bransfield y alrededores de la Isla Elefante. Se derivaron los valores de b20 a partir de le ecuación de TS de FOOTE (1990), de las longitudes promedios de los individuos capturados durante cada uno de los lances y de las tablas de TS generadas por la ecosonda, determinándose una ecuación de TS para el krill en un rango de longitud comprendido entre 2,1 y 5,3 cm de la siguiente forma: TS = 20 log L - 89,26. Se discute el posible sesgo de la ecuación debido, entre otros aspectos a que no se consideraron los estadíos sexuales del krill.

Global surveillance of cancer survival 1995-2009 : analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75 000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems. FUNDING: Canadian Partnership Against Cancer (Toronto, Canada), Cancer Focus Northern Ireland (Belfast, UK), Cancer Institute New South Wales (Sydney, Australia), Cancer Research UK (London, UK), Centers for Disease Control and Prevention (Atlanta, GA, USA), Swiss Re (London, UK), Swiss Cancer Research foundation (Bern, Switzerland), Swiss Cancer League (Bern, Switzerland), and University of Kentucky (Lexington, KY, USA).

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-standardised adult prevalence of diabetes at its 2010 levels. We aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the global target, and how changes in prevalence, together with population growth and ageing, are affecting the number of adults with diabetes. We pooled data from population-based studies that had collected data on diabetes through measurement of its biomarkers. We used a Bayesian hierarchical model to estimate trends in diabetes prevalence-defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs-in 200 countries and territories in 21 regions, by sex and from 1980 to 2014. We also calculated the posterior probability of meeting the global diabetes target if post-2000 trends continue. We used data from 751 studies including 4,372,000 adults from 146 of the 200 countries we make estimates for. Global age-standardised diabetes prevalence increased from 4.3% (95% credible interval 2.4-7.0) in 1980 to 9.0% (7.2-11.1) in 2014 in men, and from 5.0% (2.9-7.9) to 7.9% (6.4-9.7) in women. The number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014 (28.5% due to the rise in prevalence, 39.7% due to population growth and ageing, and 31.8% due to interaction of these two factors). Age-standardised adult diabetes prevalence in 2014 was lowest in northwestern Europe, and highest in Polynesia and Micronesia, at nearly 25%, followed by Melanesia and the Middle East and north Africa. Between 1980 and 2014 there was little change in age-standardised diabetes prevalence in adult women in continental western Europe, although crude prevalence rose because of ageing of the population. By contrast, age-standardised adult prevalence rose by 15 percentage points in men and women in Polynesia and Micronesia. In 2014, American Samoa had the highest national prevalence of diabetes (>30% in both sexes), with age-standardised adult prevalence also higher than 25% in some other islands in Polynesia and Micronesia. If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is lower than 1% for men and is 1% for women. Only nine countries for men and 29 countries for women, mostly in western Europe, have a 50% or higher probability of meeting the global target. Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchanged, in every country. Together with population growth and ageing, this rise has led to a near quadrupling of the number of adults with diabetes worldwide. The burden of diabetes, both in terms of prevalence and number of adults affected, has increased faster in low-income and middle-income countries than in high-income countries. Wellcome Trust.

L'expérience et approbation, Ulrich de Hutem,... : touchant la médecine du boys dit guaiacii pour circonvenir et déchasser la maladie de Neaples ([Reprod.]) / traduicte et interprétée par maistre Jehan Cheradame,...

Collection : French books before 1601 ; 413.3

L'Écho de Paris

1888/06/16 (Numéro 1547).

L'Écho de Paris

1888/05/30 (Numéro 1530).

Epistolae Pauli cum glossa ordinaria.

F. 1 Maximes tirées des Pères : « Mulier est caput peccati... » etc. (XIIe et XVIe s.) ; Vers rythmiques : « Vinea culta fuit... » (XVIe s.) (Hervieux, Fabulistes lat., IV, 353). F. 2v Epist. Pauli ad Laodicenses. F. 3 « Divisio prime epistole ad Romanos ». F. 5 XIV. Epist. Pauli, cum glossa ordinaria. F. 187 Note en espagnol relative au prix du blé en 1528 et à un arrêt de la cour de Navarre du 27 nov. 1530. F. 188 Fragm. de grammaire commençant par 4 distiques : « [J]anua sum rudibus... Poeta. Que pars... — ... hec manus, genitivo harum. » (Écriture bolonaise, XIIIe-XIVe s.).

Imprimeurs et libraires parisiens du XVIe siècle. Jean Loys / ouvrage publ. d'après les manuscrits de Philippe Renouard ; par le Service des travaux historiques de la Ville de Paris, avec le concours de la Bibliothèque nationale ; [réd. par Marie-Josèphe Beaud-Gambier et Sylvie Postel-Lecocq]

Collection : Histoire générale de Paris

Legendarius per circulum anni, pars.

Légendier disposé dans l'ordre du calendrier liturgique du 20 juillet au 25 novembre et contenant les saints suivants: ss. Margarita, Maria Magdelene, Jacobus major ap., Stephanus, Laurentius, Hippolytus, assumptio b. Mariae, Bartholomaeus, Augustinus, Johannes Baptista, Aegidius, nativitas b. Mariae, Gorgonius, Protus et Hyacinthus, exaltatio s. Crucis, Euphemia, Matthaeus, Mauritius, Cosmas et Damianus, Michael archangelus, Hieronymus, Leodegarius, Dionysius, Lucas, Simon et Judas, Martinus, Caecilia, Clemens, Catharina. F. 1-130. Legendarius. F. 1-3v. "... passio sancte Margarete virginis"; cf. B.H.L. n° 5306. F. 3v-6v. "... vita sancte Marie Magdalene" [ODO Cluniacensis abbas, sermo 2, excerptum] (P.L. 133, 714B-719C); cf. B.H.L. n° 5440. F. 6v-8v. "... passio sancti Jacobi [majoris] apostoli" incomplet des lignes finales par lacune matérielle, à partir de "decollandi erant dixit [Jacobus...]" [Virtutes apostolorum, de s. Jacobo majore] (Mombritius, 2a ed., II, 37-40 lig. 15); cf. B.H.L. n° 4057; C.A.N.T. n° 272. F. 9-12. "Inventio sancti Stephani prothomartyris" [LUCIANUS presbyter, interprete AVITO presbytero Bracarensi ]. "Domino venerabili Nimpsio [sic] episcopo... [Julianus exponctué et corrigé en] Lucianus... Revelationem que mihi ostensa est...-... aperire dignatus est..." recensio mixta suivie d'un court épilogue: "Bovem appellatum... declarata sunt"; cf. C.P.L. n° 575; B.H.L. Suppl. n° 7851n (E. Vanderlinden, Rev. des études byzantines, IV, 1946, 190-216, version A'; ne fait pas partie des mss. recensés pour l'édition). F. 12-16. "... passio sancti [Sixti et sancti] Laurentii". "In illo tempore Decius Caesar et Valerianus prefectus jusserunt...-... participati sunt omnes"; cf. B.H.L. Suppl. n° 7801 avec var. incipit et n° 4754. F. 16-18. "... passio sancti Ypoliti et sociorum ejus". "Egressus itaque Ypolitus post tercium diem...-... vivere male et regnare cum Christo "; cf. B.H.L. n° 3961 avec var. incipit et explicit. F. 18-31. "... [sermo] beati Ieronimi in assumptione sancte Virginis" [PASCHASIUS RADBERTUS, De Adsumptione b. Mariae] (C.C.C.M., LVI C 109-162; édité aussi parmi les apocryphes de saint Jérôme, P.L., XXX, 126-147); cf. C.P.L. n° 633, ep. 9 (18-29). F. 29-31. Addition contemporaine : "In vigilia assumptionis beate Marie legatur: Secundum Lucam (Lc 11, 27). [M]agne devocionis et fidei...-... ubera que suxisti" [BEDA, In Lc, l. IV, excerptum] divisé en trois paragraphes, correspondant sans doute à trois leçons (P.L., XCII, 479 C-480 B; C.C.S.L., CXX, 236-237 lig. 213-244) (29). — "Sermo iste legatur in nativitate beate Marie virginis"; cf. infra f. 56v. "[A]pprobate consuetudinis est apud christianos...-... pacta cessare" [FULBERTUS CARNOTENSIS, sermo 4] incomplet de la fin qui a été laissée en blanc (P.L. CXLI, 320-324 A; J.M. Canal, dans Rech. théol. anc. méd., XXX (1963), 56-61 lig. 168); ne fait pas partie des mss. répertoriés par J.M. Canal, ibid., XXIX (1962), 36-37; division marginale en neuf, puis en trois fois trois leçons; en marge du titre, une note difficilement lisible identifie l'auteur: "sermo Fulberti ep. Carnotensis" (29v-31). F. 32-35. "... vita [sic pro passio] sancti Bartholomei apostoli" [Virtutes apostolorum, de s. Bartholomaeo]; cf. B.H.L. Suppl. n° 1002a; C.A.N.T. n° 259. F. 35-49v. "[Vita s.] Augustini episcopi", sans prologue [POSSIDIUS]. "Ex provincia affricana civitate...-... perfruar"; cf. B.H.L. n° 785; C.P.L. n° 358 (35-49a lig. 7); suivi de la liste des livres de s. Augustin dans l'ordre des Retractations : "Libros vero quod edidit hic breviter enumerare vel annotare non omissi. Et hoc indicium librorum omnium sancti Augustini. Contra paganos achademicos [sic] libri III. De beata vita liber I. De ordine sacro libri II. De soliloquiis...-... et gratia liber. Requievit autem... V. kal. septembris..." (C.C.S.L., LVII (1984), 1-4, var.); texte proche du ms. lat. 5276, ff. 136v-137, répertorié par A. Wilmart, Miscellanea Agostiniana, Roma, 1931, 157 (Testi e studi, 2) (49a lig. 7-49v). F. 49v-52v. "Inventio capitis sancti Johannis Baptiste"; cf. B.H.L. n° 4296 (49v-51). — "De translatione ejusdem [Angeriacum]"; cf. B.H.L. n° 4297 (51-52v). F. 52v-56v. "... vita sancti Egidii"; cf. B.H.L. n° 93. F. 56v-59v. "De nativitate sancte Marie". "Petis a me petitiunculam opere...-... prefationem habuisse"; cf. B.H.L. Suppl. n° 5345 (56v a-b lig. 27) ; suivi de: "Petitis a me...-... scribi potuerunt. Igitur beata et gloriosissima semper virgo Maria..-... docuerunt Dominum..." (éd. parmi les apocryphes de s. Jérôme, P.L., XXX, 2a ed., 307-317); cf. B.H.L. n° 5344-5343; C.P.L., n° 633, ep. 50 (56v b lig. 27-59v). L'attribution à Paschase Radbert des deux lettres regroupées en une seule faite par C. Lambot, dans Rev. bénéd., XLVI (1934), 271-282, est réfutée par R. Beyers, dans Rev. Théol. et Philos., CXXII (1990), 171-188. Voir sa nouv. éd. dans CC Apocrypha, 10. F. 59v-61v. "Passio sancti Gorgonii [et Dorothei]; cf. B.H.L. n° 3617. F. 61v-62. "[Passio ss.] Prothi et Jacincti"; cf. B.H.L. n° 6977. F. 62-63v. "De exaltatione sancte Crucis". "Tempore illo postquam Constantino Augusto contra Maxentium..."; cf. B.H.L. n° 4178, avec var. incipit. F. 64-68v. "[Passio s.] Eufemie virginis". "Quinto persecutionis anno Diocletiani...-... Completum est autem martyrium... Prisco proconsule Europe..."; cf. B.H.L. n° 2709, avec var. explicit. F. 68v-72v. "[Passio] sancti Mathei apostoli" [Virtutes apostolorum, de s. Jacobo majore]; cf. C.A.N.T. n° 270; B.H.L. n° 5690, avec var. explicit de l'épilogue: "Zaroes autem...-... passio eorum ostendit". F. 72v-76. "[Passio s.] [Marcii corrigé en] Mauricii con [sic] sociis suis" [s. EUCHERIUS LUGDUNENSIS] sans le prologue; cf. B.H.L. n° 5738; C.P.L. n° 490. F. 76-79v. "[Passio ss.] Cosme et Damiani"; cf. B.H.L. Suppl. n° 1975. F. 79v-80. "[In festivitate s.] Michaelis archangeli". "Angelorum quippe et hominum naturam...-... medicina Dei." [GREGORIUS MAGNUS, Hom. in Ev., 34, excerptum]; C.P.L. n° 1711 (P.L., LXXVI, 1249 C-1251 A, §§ 6, fin-9 début) divisé en 8 paragraphes; une interpolation a été ajoutée dans la marge inférieure du f. 79v par une main contemporaine qui a également numéroté les paragraphes en IX leçons, le texte ajouté formant la lectio IIa : "[N]ovem esse angelorum ordines ad Dei judicia...-... principantur."; il s'agit d'un court extrait du sermon Legimus in ecclesiasticis historiis édité par J. E. Cross, dans Traditio, 33 (1977), 108-109 lig. 41-47 (Beda, Homilia subditia 71, P.L., XCIV, 453 C); cf. C.P.P.M., I, 4046. F. 80-82v. "[Vita s.] Jeronimi presbiteri". "Hieronimus noster [corrigé en: presbiter] in oppido Stridonis...-... etatis sue anno in Domino requievit cui..." extraits de la Vie apocryphe de Gennadius (P.L., XXII, 175-184, passim, avec var.); cf. C.P.L. n° 623; B.H.L. n° 3869; Lambert, B.H.M., IIIA, 630 (80-81b lig. 26); suivi du miracle du lion extrait de la Vie du Ps. Sebastianus Casinensis: "Contigit autem hujusmodi miraculum in monasterio... Quadam namque die ingens leo... - asserendo narrantur" (P.L., XXII, 210 lig. 11-213 lig. 11); cf. C.P.L. n° 622; B.H.L. n° 3872 avec var. incipit; Lambert, B.H.M., IIIA, 630 (81b lig. 26-82v). F. 82v-88v. "[Vita s.] Leodegarii". "Igitur sanctus Leodegarius ex progenie...-... postmodum cecum. ... adnecteret opera ibidem" [URSINUS LOGOGIACENSIS] sans le prologue et incomplet de la fin (C.C.S.L., CXVII, 589-632 lig. 14, avec var.); cf. C.P.L. n° 1079a; B.H.L. n° 4851; suivi d'un court extrait omis à sa place plus haut dans le texte: "Deinde vero ire ceperunt... Dei opera ibidem" (ed. cit., 631 § 31 lig. 3-7). F. 88v-98. "[Passio] sancti Dyonisii martyris", texte incomplet par suite de la perte de 2 ff. entre les ff. 96 et 97, le texte s'arrête à "...fideliter adhe[-rebat]" et reprend à "[Domitia-]no per tres Cesares..." (P.L., CVI, 23-40 C et 48 A-50); cf. B.H.L. n° 2175. F. 98-100v. "[Laudatio s.] Luce evvangeliste". "Gloriosus igitur evvangelista Jhesu Christi Lucas natione Syrus...-... ubique confluunt qui ..." [PAULUS DIACONUS, hom. 59] incomplet du prologue (P.L., XCV, 1530-1535, avec var.); cf. B.H.L. n° 4974, d'après ce ms. F. 100v-106. "[Passio ss.] Symonis et Jude apostolorum" avec l'épilogue [ABDIAS, Virtutes Simonis et Judae Thaddaei]; cf. B.H.L. n° 7750-7751; C.A.N.T. n° 284. F. 106-107v. "[Laudatio] sancti Martini archiepiscopi" [ALCUINUS, De vita s. Martini, pars I]; cf. B.H.L. n° 5625. — GREGORIUS TURONENSIS, De virtutibus s. Martini; cf. B.H.L. n° 5618; seule l'adresse du prologue, introduite par une initiale filigranée, a été copiée au bas du f. 107v, col. b: "Domnis sanctis et in Christi amore dulcissimis fratribus... Gregorius peccator", le texte lui-même manque, soit en raison de la perte du cahier suivant, soit qu'il n'ait pas été copié. F. 108-115v. "[Passio s.] Cecilie virginis et martyris"; cf. B.H.L. Suppl. n° 1495a. F. 115v-118v. "[Passio s.] Clementis pape". [Prologus] "Postquam igitur beatus Petrus apostolus in Antiochia cathedram... -... passio secuta est"; cf. B.H.L. Suppl. n° 1849, d'après ce ms. (115v-116a, lig. 11); — "Tunc sanctus Clemens romane ecclesie episcopus disciplinam...-... Cersone Licie provincie"; C.P.L. n° 2177; B.H.L. n° 1848 (Mombritius, 2a ed., I, 341-344, var. à l'incipit et à l'explicit); suivi de: "Oremus fratres ut Dominus... participes. Per..." (116a, lig. 11-118v). F.118v-130. "[Passio] sancte Katerine virginis et martyris"; cf. B.H.L. n° 1663, sans le prologue. F. 130-130v. Additions. Table des saints contenus dans le volume, XIVe s. (130). — Prière latine en 10 strophes de deux vers, XVe s.: "Jhesu tue matris prece ab Orci me serva nece...-... ab inferi atris" (130v).

historia Pontificum ecclesiae Barcinonensis, à prima origine ad Jacobum II. et annum 1546. authore Francisco Taraffa, Canonico Barcinonensi.

Baluzianus